Clinical Trials Logo

Clinical Trial Summary

The SchlaHF XT Registry is a longitudinal study of patients with heart failure (HF). The study aims to understand the importance of diagnosis and treatment of sleep disordered breathing (SDB) on HF with the following questions:

How often does SDB occur in HF? What forms of SDB occur and how are they treated? How does SDB develop over time? How does the heart failure therapy affect SDB? What is the treatment adherence of patients treated? Does SBD and its treatment affect the survival of heart failure patients?


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT02301689
Study type Observational [Patient Registry]
Source ResMed
Contact
Status Completed
Phase
Start date May 2014
Completion date June 2018

See also
  Status Clinical Trial Phase
Completed NCT03456856 - A Study of Ivabradine in African-American/ Black Subjects With Heart Failure and Left Ventricular Systolic Dysfunction. Phase 4
Completed NCT03901729 - A Trial to Study BAY1753011 in Patients With Congestive Heart Failure Phase 2
Completed NCT04915118 - A Study Called NATION-OS to Learn About the Link Between N-terminal proBNP (NT-proBNP) Levels and Medical Problems Due to Heart Failure (HF) in German Patients With HF
Completed NCT02200822 - Systematic Withdrawal of Neurohumoral Blocker Therapy in Optimally Responding CRT Patients Phase 4
Recruiting NCT04149743 - HEMOTAG® Assessment for Short-term Outcomes of Heart Failure N/A
Recruiting NCT05652218 - REsynchronization Comparison In LBBB and Normal or Mildly Reduced VENTricular Function With CRT (REINVENT-CRT) N/A
Completed NCT02127307 - Phase 4 Study to Demonstrate Prognostic Usefulness of AdreView™ Scintigraphy for Identifying Subjects With Heart Failure Who Will Experience Death During 60 Months Follow-up. N/A
Completed NCT01936649 - Open-label, Test-retest Study Assessing Reproducibility of Quantitative Measurements of Myocardial Uptake of AdreView. Phase 4